SBC Medical Group Holdings Incorporated
SBC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $536,880 | $1,088,027 | $1,027,581 |
| - Cash | $125,044 | $103,023 | $51,738 |
| + Debt | $12,214 | $22,866 | $16,130 |
| Enterprise Value | $424,050 | $1,007,871 | $991,973 |
| Revenue | $205,416 | $193,542 | $174,161 |
| % Growth | 6.1% | 11.1% | – |
| Gross Profit | $156,051 | $137,304 | $114,833 |
| % Margin | 76% | 70.9% | 65.9% |
| EBITDA | $77,283 | $85,872 | $29,640 |
| % Margin | 37.6% | 44.4% | 17% |
| Net Income | $46,614 | $39,370 | $6,315 |
| % Margin | 22.7% | 20.3% | 3.6% |
| EPS Diluted | 0.483 | 0.418 | 0.037 |
| % Growth | 15.5% | 1,039% | – |
| Operating Cash Flow | $20,583 | $50,644 | -$47 |
| Capital Expenditures | -$3,408 | -$11,208 | -$24,945 |
| Free Cash Flow | $17,175 | $39,436 | -$24,993 |